Impact of depressive mood on lifestyle changes in patients with coronary artery disease

Eva Söderman1, Jan Lisspers, Orjan Sundin

  • 1Department of Social Sciences, MidSweden University, Ostersund, Sweden. eva.soderman@miun.se

Insights

Patients with coronary artery disease showed reduced depressive mood during rehabilitation. Higher initial depression levels did not hinder lifestyle changes, suggesting rehabilitation programs benefit mood and behavior.

Area of Science:

  • Cardiology
  • Psychiatry
  • Rehabilitation Medicine

Background:

  • Coronary artery disease (CAD) patients often experience depressive mood, impacting secondary prevention efforts.
  • Understanding the trajectory of depressive mood and its influence on lifestyle modifications is crucial for effective cardiac rehabilitation.

Purpose of the Study:

  • To examine the time-course of depressive mood in CAD patients undergoing cardiac rehabilitation.
  • To determine if pre-treatment depressive mood levels affect lifestyle changes at 36-month follow-up.

Main Methods:

  • 109 CAD patients (post-MI, bypass surgery, angioplasty, or untreated angina) were assessed for depressive mood at baseline, 4 weeks, and 12 months using the Hospital Anxiety and Depression scale.
  • Patients were categorized into three subgroups based on initial depressive mood levels.
  • Lifestyle changes in diet, smoking, stress management, and exercise were evaluated over 36 months.

Main Results:

  • Depressive mood significantly decreased at 4 weeks and 12 months compared to baseline.
  • Patients with higher initial depression scores showed the greatest mood improvement.
  • Pre-treatment depressive mood levels did not predict the extent of lifestyle habit changes over 36 months.

Conclusions:

  • Behaviorally oriented rehabilitation programs, including exercise, may improve depressive mood in CAD patients.
  • Depressive mood may not be a barrier to adopting healthier lifestyles within such programs.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...